PriC stimulation of DNA replication initiation inhibited by DiaA oversupply.
(A) Colony forming abilities of MG1655, KRC002 (MG1655 ΔpriC::frt-kan), and FF001 (MG1655 Δrep::frt-kan) cells bearing pBR322 or pNA135 (pBR322 derivatives carrying diaA). Overnight cultures (∼109 cells/mL) of MG1655 and KRC002 cells bearing pBR322 or pNA135 were 10-fold serially diluted and incubated on LB agar plates containing ampicillin for 40 h at 25℃. The results of three independent experiments were consistent, and one which is shown.
(B) Flow cytometry analyses of MG1655 and KRC002 (MG1655 ΔpriC::frt-kan) cells bearing pBR322 or pNA135. Cells were exponentially grown at 30℃ in LB medium with ampicillin, followed by further incubation with rifampicin and cephalexin to allow run-out of chromosomal DNA replication. DNA contents were quantified by flow cytometry, and cell size (mass) at the time of drug addition was measured by a Coulter counter. Mean mass, ori/mass ratio, doubling time (Td), and asynchrony index (A.I.: the percentage of cell numbers with non-2n copies of oriC per the cell numbers with 2n copies of oriC) of each strain are indicated at the top right of each panel with standard deviations. Three to four independent experiments were performed. +, WT priC; −, ΔpriC::frt-kan.
(C) Flow cytometry analyses of MG1655, KRC003 (MG1655 ΔpriC::frt), SA103 (MG1655 ΔdiaA::frt-kan), and KRC006 (MG1655 ΔpriC::frt, ΔdiaA::frt-kan) cells. Cells were grown and analyzed as described above. Three independent experiments were performed. For “priC” column, +, WT priC; −, ΔpriC::frt. For “diaA” column, +, WT diaA; −, ΔdiaA::frt-kan.